Fluicell

Fluicell

Forskning inom bioteknik

Mölndal, Vastra Gotaland County 3 274 följare

Making tissue therapeutics possible to defeat serious disease

Om oss

Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable our world-leading partners to advance their drug-screening capabilities for the development of game-changing medicines.

Bransch
Forskning inom bioteknik
Företagsstorlek
2–10 anställda
Huvudkontor
Mölndal, Vastra Gotaland County
Typ
Publikt aktiebolag
Grundat
2012
Specialistområden
Biotechnology, Bioprinting, Microfluidics, Biomedicine, Single-Cell Biology, Single-Cell Pharmacology, regenerative medicine, diabetes och cell therapy

Adresser

Anställda på Fluicell

Uppdateringar

Anslutna sidor

Liknande sidor